TrialNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2016

The α7 Nicotinic Agonist ABT-126 in the Treatment of Cognitive Impairment Associated with Schizophrenia in Nonsmokers: Results from a Randomized Controlled Phase 2b Study.

George Haig et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.